A new study shows that a diabetes treatment awaiting FDA approval may also work as a weightloss drug.
Monday, 15 Jun 2009 | Source: The Associated Press
Pharmaceutical company Novo Nordisk said Saturday that a batch of insulin stolen from North Carolina resurfaced recently at a medical center in Houston and should not be used.
Posts |
COMPANY : Novo Nordisk A/S
6 Nov 2009
Don't let the pundit-speak about "lagging indicator" or the market's move Friday fool you, the job market is crucial to the stock market right now.... Read More
3 Nov 2009
Companies including TD Ameritrade, Coach and Turkey's Turkcell could be on Warren Buffett's radar, according to a quantitative screen by Standard & Poor's.... Read More
1 Jul 2009
Here's our Fast Money Final Trade... Read More
26 Jun 2009
Shares of the French drugmaker are getting pummeled over at least three analyst reports identifying a leak about a study or studies that could go public soon... Read More
8 Jun 2009
For people struggling with diabetes, the bathroom scale can be the enemy... Read More
VIDEO | COMPANIES : Novo Nordisk A/S
Diabetes is a global epidemic that presents an estimated $25 billion drug and device market and some predict that number...
More Videos
About CNBC | Site Map | Privacy Policy | Terms of Service | Video Reprints | Advertise | Help | Contact
Partners: AOL Money | BloggingStocks.com
Partners: AOL Money | BloggingStocks.com
Data is a real-time snapshot *Data is delayed at least 15 minutesGlobal Business and Financial News, Stock Quotes, and Market Data and Analysis
© 2009 CNBC, Inc. All Rights Reserved.
A Division of NBC Universal
